Skip to main content

2 October 2023

Last updated: Monday 2 October 2023

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Innate Pharma's anti-cancer platform attracts BMS investment

Friday 15 July 2011

Interviewee/Contributor

Herve Brailly

Organisation

Innate Pharma SA

How Innate Pharma turned a threat into an opportunity

Monday 10 November 2008

Interviewee/Contributor

Herve Brailly

Organisation

Innate Pharma SA

Organisations

Rinri Therapeutics Ltd
Stanford University School of Medicine
LifeSci Advisors
Harvard Stem Cell Institute
TI Pharma
CureVac GmbH
The PEW Charitable Trusts
Ariceum Therapeutics GmbH
VectorY Therapeutics BV
Andera Partners

Interviewees and Contributers

Nick Bassil
Michael Watson
Jan Fagerberg
Michael L Roberts
Iain McGill
Chris Parker
Alex Karlsson-Parra and Sijme Zeilemaker
Stuart Naylor
Maxime Feyeux
Andy Smith

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Sanofi appoints new head of R&D

Sunday 17 September 2023

Rishi Shah to head chemistry at Ubiquigent

Sunday 17 September 2023

Christina Ackermann joins Verona Pharma

Sunday 17 September 2023

New CEO at Oxford Science Enterprises

Sunday 17 September 2023

Louis Kayitalire becomes CMO at Nanobiotix

Sunday 17 September 2023

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2023 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form